Fair enough.
This is the chapter that is really concerning to a lot of Canadians, because this chapter contains a provision that will extend drug patents and increase the cost of drugs to Canadians. I think someone in our earlier panel spoke to exactly this type of situation, where when you see the benefits and you're looking at it sector-specifically, you're taking a narrow view of an extremely huge piece of trade legislation, at 6,000 pages. I would venture a guess that neither of you would want to support increased drug costs for Newfoundland and Labrador people.
I'm going to ask our other participants, Mr. Kavanagh and Mr. Hynd, if they can elaborate on what the impact of increased drug costs would be to the people in Newfoundland and Labrador, and if it's similar to what we've heard in other provinces where people are already struggling under the high cost of drugs.